Accumulated Depreciation - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corcept Therapeutics Inc
Accumulated Depreciation Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accumulated Depreciation
-$28.3B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Bristol-Myers Squibb Co
NYSE:BMY
Accumulated Depreciation
-$5.1B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Pfizer Inc
NYSE:PFE
Accumulated Depreciation
-$16.6B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Accumulated Depreciation
-$19B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Accumulated Depreciation
-$11.4B
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
-4%

See Also

Back to Top